Song Xiaoyan, Jin Yong, Yan Mingyu, Zhang Yonggang, Chen Bing
Department of Stomatology, Inner Mongolia Autonomous Region Maternal and Child Health Hospital, Hohhot, Inner Mongolia 010020, P.R. China.
Department of Stomatology, Tong-Liao City Hospital of Inner Mongolia, Tong Liao, Inner Mongolia 028000, P.R. China.
Oncol Lett. 2019 Jan;17(1):688-696. doi: 10.3892/ol.2018.9637. Epub 2018 Oct 29.
Although microRNA-342-3p (miR-342-3p) deregulation has been implicated in the development of a variety of cancer types, its role in oral squamous cell carcinoma (OSCC) progression remains unclear. Overexpression of LIM and SH3 protein 1 (LASP1) in OSCC tissues, and its promotion of OSCC cell proliferation were recently reported. However, the regulatory mechanism underlining LASP1 expression remains unknown. In the present study, the notable downregulation of miR-342-3p in OSCC cell lines and clinical specimens was revealed. The Cell Counting kit-8 and 5-bromo-2-deoxyuridine-incorporation assays demonstrated that miR-342-3p suppressed OSCC cell proliferation. Additionally, LASP1 was identified as a target gene of miR-342-3p through bioinformatics analysis and luciferase reporter assays. Further experiments suggested that overexpression of LASP1 attenuated the suppressive effect of miR-342-3p on the proliferation of OSCC cells. In conclusion, the present data suggest that miR-342-3p functions as a tumor suppressor in OSCC via targeting of LASP1 and may be a promising therapeutic target for OSCC.
尽管微小RNA-342-3p(miR-342-3p)失调与多种癌症类型的发生发展有关,但其在口腔鳞状细胞癌(OSCC)进展中的作用仍不清楚。最近有报道称,OSCC组织中LIM和SH3蛋白1(LASP1)过表达,且其促进OSCC细胞增殖。然而,LASP1表达的调控机制仍不清楚。在本研究中,揭示了OSCC细胞系和临床标本中miR-342-3p明显下调。细胞计数试剂盒-8和5-溴-2'-脱氧尿苷掺入试验表明,miR-342-3p抑制OSCC细胞增殖。此外,通过生物信息学分析和荧光素酶报告基因试验,确定LASP1是miR-342-3p的靶基因。进一步的实验表明,LASP1过表达减弱了miR-342-3p对OSCC细胞增殖的抑制作用。总之,目前的数据表明,miR-342-3p通过靶向LASP1在OSCC中发挥肿瘤抑制作用,可能是OSCC有前景的治疗靶点。